NCT00000712View on ClinicalTrials.gov

A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 1994

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Acyclovir

Trial Locations (8)

27401

Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro

27599

Unc Aids Crs, Chapel Hill

55455

University of Minnesota, ACTU, Minneapolis

98122

University of Washington AIDS CRS, Seattle

02118

Bmc Actg Crs, Boston

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

01655

Massachusetts General Hospital ACTG CRS, Worcester

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH